CV outcomes and all-cause mortality The HRs (95% CIs) for the reduction in risk of three-component MACE (primary endpoint) with semaglutide vs placebo in the metformin and no-metformin subgroups were 0.70 (0.55;0.89) and 0.86 (0.60;1.22), respectively, in the adjusted analysis (Fig
Side effects are uncommon and typically very mild, like a little soreness or redness at the injection site
Health Canada has a target of 180 days to assess generic drug applications, though spokesperson Marie-Pier Burelle wrote on March 25 that reviews may take longer if data is missing or additional data are required, with the review clock pausing while the regulator awaits additional information from manufacturers [Source: theglobeandmail.com/business/economy/article-apotex-fda-approval-generic-ozempic-drug-health-canada-decisions/]
doi: 10.3390/brainsci14050421, 170 RobertsL
Getting started is easy: find your nearest Medi-Weightloss clinic and schedule a free assessment
Average weight loss of 20.7% over 72 weeks in STEP UP